Page last updated: 2024-09-05

sb 203580 and etoposide

sb 203580 has been researched along with etoposide in 6 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(etoposide)
Trials
(etoposide)
Recent Studies (post-2010) (etoposide)
3,48941,13718,3063,6934,900

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)etoposide (IC50)
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]Homo sapiens (human)1.153
nuclear receptor coactivator 3 isoform aHomo sapiens (human)1.4284
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)3.187
Caspase-3Homo sapiens (human)1
DNA topoisomerase 2-betaHomo sapiens (human)0.4299
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.18

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biemann, HP; Blenis, J; Davis, RJ; Juo, P; Konz, RF; Kuo, CJ; Raingeaud, J; Reynolds, SE1
Bushell, M; McKendrick, L; Morley, SJ1
Chang, JH; Eberhardt, W; Frank, S; Mühl, H; Nold, M; Pfeilschifter, J1
Boldt, S; Kolch, W; Weidle, UH1
Baik, JH; Chaqour, B; Chung, KC; Kim, KH; Lau, LF; Min, YK1
Canepa, E; Colla, R; De Ciucis, CG; Domenicotti, C; Furfaro, AL; Marengo, B; Marinari, UM; Pronzato, MA; Ricciarelli, R; Traverso, N1

Other Studies

6 other study(ies) available for sb 203580 and etoposide

ArticleYear
Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases.
    Molecular and cellular biology, 1997, Volume: 17, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caenorhabditis elegans Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Caspase 1; Caspases; Cysteine Endopeptidases; Dactinomycin; Enzyme Activation; Enzyme Inhibitors; Etoposide; fas Receptor; Helminth Proteins; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MAP Kinase Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protease Inhibitors; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Pyridines; Serpins; Signal Transduction; Sorbitol; Transcription, Genetic; Viral Proteins

1997
Cleavage of translation initiation factor 4G (eIF4G) during anti-Fas IgM-induced apoptosis does not require signalling through the p38 mitogen-activated protein (MAP) kinase.
    FEBS letters, 1998, Oct-30, Volume: 438, Issue:1-2

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Arsenites; Calcium-Calmodulin-Dependent Protein Kinases; Caspase Inhibitors; Cell Survival; Etoposide; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; fas Receptor; Humans; Imidazoles; Immunoglobulin M; Jurkat Cells; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Peptide Initiation Factors; Phosphorylation; Poly(A)-Binding Proteins; Protein Biosynthesis; Pyridines; RNA-Binding Proteins; Signal Transduction; Sirolimus

1998
Expression and release of chemokines associated with apoptotic cell death in human promonocytic U937 cells and peripheral blood mononuclear cells.
    European journal of immunology, 1999, Volume: 29, Issue:10

    Topics: Apoptosis; Chemokines; Cladribine; Enzyme Inhibitors; Etoposide; Humans; Imidazoles; Interleukin-8; Leukocytes, Mononuclear; Pyridines; Serine Proteinase Inhibitors; Tosylphenylalanyl Chloromethyl Ketone; Triazenes; Tumor Necrosis Factor-alpha; U937 Cells

1999
The role of MAPK pathways in the action of chemotherapeutic drugs.
    Carcinogenesis, 2002, Volume: 23, Issue:11

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Cycle; Ceramides; Enzyme Activation; Enzyme Inhibitors; Etoposide; Female; Flavonoids; HeLa Cells; Humans; Imidazoles; MAP Kinase Signaling System; Microtubules; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Paclitaxel; Pyridines; Skin Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay

2002
Expression of angiogenic factor Cyr61 during neuronal cell death via the activation of c-Jun N-terminal kinase and serum response factor.
    The Journal of biological chemistry, 2003, Apr-18, Volume: 278, Issue:16

    Topics: Animals; Apoptosis; Blotting, Northern; Blotting, Western; Cell Death; Cysteine-Rich Protein 61; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Etoposide; Glutathione Transferase; Hippocampus; Imidazoles; Immediate-Early Proteins; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Neurons; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Precipitin Tests; Promoter Regions, Genetic; Protein Binding; Pyridines; Rats; RNA; RNA, Messenger; Serum Response Factor; Signal Transduction; Stem Cells; Time Factors; Transfection

2003
p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.
    Cell death & disease, 2013, Apr-11, Volume: 4

    Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Neoplasm Proteins; Neoplasm Staging; Nervous System Neoplasms; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction

2013